Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Australian collaborative trial of antenatal thyrotropin-releasing hormone: adverse effects at 12-month follow-up|
|Citation:||Pediatrics, 1997; 99(3):311-317|
|Publisher:||AMER ACAD PEDIATRICS|
|Organisation:||ACTOBAT Study Group|
|Caroline Anne Crowther, Janet Esther Hiller, Ross Roger Haslam and Jeffrey Samuel Robinson|
|Abstract:||Reports a 12-month follow up of the health and development of the children entered into the Australian Collaborative Trial of Antenatal Thyrotropin-Releasing Hormone (ACTOBAT). Long term adverse effect of Thyrotropin-Releasing Hormone (TRH); Milestone differences detected between comparison groups and those not exposed to TRH in utero.|
|Keywords:||Humans; Respiratory Distress Syndrome, Newborn; Glucocorticoids; Drug Therapy, Combination; Prenatal Care; Infant Mortality; Logistic Models; Follow-Up Studies; Developmental Disabilities; Pregnancy; Adult; Infant, Newborn; Female; Obstetric Labor, Premature; Male; Thyrotropin-Releasing Hormone|
|Rights:||Copyright © 1997 by the American Academy of Pediatrics|
|Appears in Collections:||Public Health publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.